Page last updated: 2024-10-18

imidazole and Sarcoma

imidazole has been researched along with Sarcoma in 1 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.

Research Excerpts

ExcerptRelevanceReference
" Alternative dosing regimens and combination with other targeted agents are needed to achieve successful development of nutlin in the clinical setting."1.42Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin. ( Chaire, V; Chibon, F; Coindre, JM; Hostein, I; Italiano, A; Lagarde, P; Laroche, A; Lesluyes, T; Lucchesi, C; Neuville, A; Tran-Cong, K, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laroche, A1
Tran-Cong, K1
Chaire, V1
Lagarde, P1
Hostein, I1
Coindre, JM1
Chibon, F1
Neuville, A1
Lesluyes, T1
Lucchesi, C1
Italiano, A1

Other Studies

1 other study available for imidazole and Sarcoma

ArticleYear
Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin.
    PloS one, 2015, Volume: 10, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Prolifer

2015